Candorium | Protalix BioTherapeutics, Inc. reports $3.1 million Q1 los

Latest News by Industry

Technology

Show more

Moody's credit rating upgrade for Cyprus opens the door to investment, president says

•

Nov 23, 2024

Stock market today: Wall Street gains ground as it notches a winning week and another Dow record

•

Nov 22, 2024

Supreme Court allows multibillion-dollar class action to proceed against Meta

•

Nov 22, 2024

Oil & Gas

Show more

ExxonMobil could partner up with Eni and Total to jointly develop natural gas deposits off Cyprus

•

Nov 22, 2024

Stock market today: Wall Street rises following last week's slide

•

Nov 18, 2024

What to know about Chris Wright, Trump's choice to run the Energy Department

•

Nov 18, 2024

Healthcare

Show more

Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys

•

Nov 12, 2024

Stock market today: Wall Street drifts lower as the Trump trade cools

•

Nov 12, 2024

Natera: Q3 Earnings Snapshot

•

Nov 12, 2024

Manufacturing

Show more

Stock market today: Wall Street gains ground as it notches a winning week and another Dow record

•

Nov 22, 2024

Stock market today: Wall Street rises with Nvidia as bitcoin bursts above $99,000

•

Nov 21, 2024

Nvidia is Wall Street's most valuable company. How it got there, by the numbers

•

Nov 21, 2024